(Q38404587)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

review article

1 reference

title

Designing drugs that combat kidney damage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

Cristian González-Guerrero

4 March 2020

author

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

Maria Dolores Sanchez-niño

4 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Marta Ruiz-Ortega

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Marta Ruiz-Ortega

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Adrián M Ramos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ana Sanz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Laura Rodríguez-Osorio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Catalina Martín-Cleary

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Beatriz Fernández-Fernández

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Alberto Ortiz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

3 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Discovery

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

541-556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Kidney transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Translational nephrology: what translational research is and a bird's-eye view on translational research in nephrology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

The number, quality, and coverage of randomized controlled trials in nephrology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Progress in the development of animal models of acute kidney injury and its impact on drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Implementation of proteomic biomarkers: making it work

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Therapeutic approaches to diabetic nephropathy--beyond the RAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Epac-Rap signaling reduces oxidative stress in the tubular epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Local therapeutic efficacy with reduced systemic side effects by rapamycin-loaded subcapsular microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Regulated cell death in AKI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Mechanisms of renal apoptosis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

A nanoconjugate Apaf-1 inhibitor protects mesothelial cells from cytokine-induced injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

A polymeric nanomedicine diminishes inflammatory events in renal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Apaf-1 inhibitors protect from unwanted cell death in in vivo models of kidney ischemia and chemotherapy induced ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Synchronized renal tubular cell death involves ferroptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

BASP1 promotes apoptosis in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Role of chemokines in proteinuric kidney disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Interleukin-17 and type 17 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

The Th17 immune response in renal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

The emergence of TH17 cells as effectors of renal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

CD4⁺CD25⁺Foxp3⁺ regulatory T cells suppress cardiac fibrosis in the hypertensive heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

IL-17A is a novel player in dialysis-induced peritoneal damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Secukinumab in plaque psoriasis--results of two phase 3 trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

TWEAK and the progression of renal disease: clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Urinary TWEAK and the activity of lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

The cytokine TWEAK modulates renal tubulointerstitial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Fn14 in podocytes and proteinuric kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Relevant role of PKG in the progression of fibrosis induced by TNF-like weak inducer of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Nitro-oleic acid protects against adriamycin-induced nephropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Alkaline phosphatase: a possible treatment for sepsis-associated acute kidney injury in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Purinergic signaling during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Angiotensin II contributes to renal fibrosis independently of Notch pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Methylation determines fibroblast activation and fibrogenesis in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Origin of regenerating tubular cells after acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Unraveling the role of podocyte turnover in glomerular aging and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Proteinuria impairs podocyte regeneration by sequestering retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

GSK3, snail, and adhesion molecule regulation by cyclosporine A in renal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Renal replacement therapy associated with lithium nephrotoxicity in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Delayed administration of a single dose of lithium promotes recovery from AKI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Formoterol restores mitochondrial and renal function after ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Toll-like receptor 4-induced IL-22 accelerates kidney regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Alpha-melanocyte stimulating hormone analogue AP214 protects against ischemia induced acute kidney injury in a porcine surgical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Erythropoietin protects against ischaemic acute renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Antiapoptotic properties of recombinant human erythropoietin protects against tubular cyclosporine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Erythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Effect of erythropoietin on the migration of bone marrow-derived mesenchymal stem cells to the acute kidney injury microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Ferroptosis: an iron-dependent form of nonapoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Deferasirox nephrotoxicity-the knowns and unknowns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Vasopressin antagonists in polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Regulation of cAMP production in initial and terminal inner medullary collecting ducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Vasopressin directly regulates cyst growth in polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Hyperosmolarity drives hypertension and CKD--water and salt revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Resolving the enigma of the mesoamerican nephropathy: a research workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

21 January 2018

A slit in podocyte death

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Role of podocyte B7-1 in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Induction of B7-1 in podocytes is associated with nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Abatacept in B7-1-positive proteinuric kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Eculizumab for the Treatment of Dense-Deposit Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Experimental membranous nephropathy redux

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Nanomedicines as cancer therapeutics: current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

The death ligand TRAIL in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Dual RAS blockade-controversy resolved.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1033394

10.1517/17460441.2015.1033394

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25840605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference